全球腫瘤人工智慧市場：按成分、按癌症類型、按治療類型、按最終用戶、按地區

Global Artificial Intelligence in Oncology Market, By Component, By Cancer Type, By Treatment Type, By End User, By Region

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球腫瘤人工智慧市場規模估計為 21.451 億美元，預計到 2032 年將達到 163.82 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 33.7%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	21.451億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年年複合成長率：	33.70%	2032年價值預測	163.82億美元

人工智慧 (AI) 在腫瘤學中發揮關鍵作用。有各種類型的 AI 產品可協助進行癌症篩檢、診斷、治療和藥物開發。其中一個主要產品是 AI 癌症篩檢工具。這些工具使用在龐大的醫學影像資料庫上訓練的深度學習演算法。它們可幫助醫生檢測 CT、MRI 和乳房 X 光檢查等掃描影像中的異常。它們可以快速分析大量影像並突出顯示醫生僅靠人工篩檢可能遺漏的可疑區域。這提高了早期腫瘤檢測的準確性並挽救了更多生命。然而，需要不斷更新新數據以改進演算法。由於 AI 可能無法有效區分罕見癌症類型，因此也存在誤診的風險。

另一個重要應用是人工智慧在癌症診斷、預後和治療的應用。透過對海量基因組和臨床癌症資料集進行機器學習，人工智慧能夠識別複雜模式，獲得新見解，並比人類更好地預測治療反應。這有助於客製化標靶治療。人工智慧也透過輔助標靶識別、化合物篩檢和最佳化臨床試驗來加速藥物開發。

市場動態：

癌症發生率的上升和癌症治療決策的日益複雜是推動腫瘤學採用人工智慧解決方案的主要驅動力。數位健康數據和運算能力的日益普及正在推動先進人工智慧技術的發展。然而，開發高精度臨床級人工智慧解決方案所需的高額投資和成本是限制其發展的主要因素。對人工智慧決策機制的缺乏解讀和理解也限制了其廣泛應用。另一方面，人工智慧透過實現個人化治療方案選擇，有望幫助克服抗藥性，這為未來帶來了機會。科技公司與研究機構之間的夥伴關係旨在進一步檢驗人工智慧的臨床應用價值。

從地區來看，北美憑藉其高昂的醫療成本和便利的醫療服務佔據市場主導地位。然而，亞太地區是成長最快的市場，主要由中國和印度等國家推動。這一成長得益於經濟成長、可支配收入的增加、醫療基礎設施的擴張以及先進癌症診斷工具的普及。

本研究的主要特點

本報告對全球腫瘤學人工智慧市場進行了詳細分析，並以 2024 年為基準年，提供了預測期 2025-2032 的市場規模和年複合成長率（CAGR%）。
它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，介紹了全球腫瘤人工智慧市場的主要企業概況。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球腫瘤學人工智慧市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
透過用於分析全球腫瘤學人工智慧市場的各種策略矩陣，相關人員可以更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 2,145.1 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	33.70%	2032 Value Projection:	USD 16,382.0 Mn

Artificial intelligence (AI) plays an important role in oncology. There are various types of AI products that are helping in cancer screening, diagnosis, treatment, and drug development. One of the major products is an AI-assisted cancer screening tool. These tools use deep learning algorithms that have been trained on huge databases of medical images. They help physicians detect abnormalities in scans like CT, MRI, or mammograms. They can rapidly analyze a large number of images and highlight suspect areas that the doctor may miss with human screening alone. This improves the accuracy of detecting tumors at early stages and increases the number of lives saved. However, the algorithms need continuous updates with new data to improve over time. Misdiagnosis is also a risk because the AI may not be able to distinguish rare cancer types effectively.

Other important applications include the use of AI in cancer diagnostics, prognosis, and therapeutics. Using machine learning on vast pools of genomic and clinical cancer datasets, AI can recognize complex patterns, emerge with new insights, and predict treatment responses better than humans. This helps with customized and targeted therapy. AI is also speeding up drug development by assisting in target identification, compound screening, and clinical trial optimization.

Market Dynamics:

Rising cancer incidence coupled with the increasing complexity of cancer treatment decisions is a key factor driving the adoption of AI solutions in oncology. The growing availability of digital health data and computational power is facilitating the development of advanced AI technologies. However, the high investment and costs required for the development of precision and clinical-grade AI solutions are a major restraint. Lack of interpretability and understanding of how AI arrives at its decisions also limits widespread adoption. Meanwhile, the potential of AI to help overcome drug resistance by enabling personalized treatment selection presents an opportunity. Partnerships between technology companies and research institutes aim to further validate the clinical applicability of AI.

Among regions, North America dominates the market due to high healthcare expenditures and better access to care. However, Asia Pacific is poised to be the fastest-growing market arena, led by countries like China and India. This growth can be attributed to growing economies, rising disposable incomes, expanding medical infrastructure, and the increasing adoption of technologically advanced cancer diagnostic tools.

Key features of the study:

This report provides in-depth analysis of the global artificial intelligence in oncology market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global artificial intelligence in oncology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Azra AI, IBM Corporation, Siemens Healthineers AG, Intel Corporation, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI, Median Technologies, PathAI, Microsoft, Zebra Medical Vision, and Babylon
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global artificial intelligence in oncology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence in oncology market

Global Artificial Intelligence in Oncology Market Segmentation:

By Component
- Software/Platform
- Hardware
- Services
By Cancer Type
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Brain Tumor
- Others
By Treatment Type
- Chemotherapy
- Radiotherapy
- Immunotherapy
- Others
By End User:
- Hospitals & Clinics
- Diagnostic Centers
- Biopharmaceutical Companies
- Others
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Azra AI
- IBm Corporation
- Siemens Healthineers AG
- Intel Corporation
- GE HealthCare
- NVIDIA Corporation
- Digital Diagnostics Inc.
- ConcertAI
- Median Technologies
- PathAI
- Microsoft
- Zebra Medical Vision
- Babylon

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Top 3 Market Findings
- Top 3 Market Opportunity

3. Key Industry Insights

Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancement
Merger, Acquisition and Collaboration Scenario
Recent Product Approvals/Launches
Company Market Share Analysis

4. Artificial Intelligence In Oncology Market, By Component Type, 2020 - 2032 ( US$ Million)

Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
- Segment Trends
Software Solutions, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Hardware, 2020 - 2032( US$ Million
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Services, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)

5. Artificial Intelligence In Oncology Market, By Cancer Type, 2020 - 2032 ( US$ Million)

Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
- Segment Trends
Breast Cancer, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Lung Cancer, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Prostate Cancer, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Colorectal Cancer, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Brain Tumor, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Others, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)

6. Artificial Intelligence In Oncology Market, By Treatment Type, 2020 - 2032 ( US$ Million)

Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
- Segment Trends
Chemotherapy, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Radiotherapy, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Immunotherapy, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Others, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)

7. Artificial Intelligence In Oncology Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2020 - 2032, ( US$ Million)
- Segment Trends
By Region
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
North America
- Introduction
- Market Size and Forecast, By Component Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Cancer Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Million)
  - U.S.
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Canada
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Europe
- Introduction
- Market Size and Forecast, By Component Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Cancer Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Million)
  - U.K
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Germany
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
France
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Italy
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Spain
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Russia
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Rest of Europe
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Asia Pacific
- Introduction
- Market Size and Forecast, By Component Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Cancer Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Million)
  - China
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
India
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Japan
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Australia
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
South Korea
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
ASEAN
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Rest of Asia Pacific
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Latin America
- Introduction
- Market Size and Forecast, By Component Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Cancer Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Million)
  - Brazil
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Mexico
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Argentina
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Rest of Latin America
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Middle East
- Introduction
- Market Size and Forecast, By Component Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Cancer Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Million)
  - GCC
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Israel
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Rest of Middle East
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Africa
- Introduction
- Market Size and Forecast, By Component Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Cancer Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Million)
  - North Africa
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Central Africa
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
South Africa
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)

8. Company Profiles - Artificial Intelligence In Oncology Market

NVIDIA Corporation
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
Digital Diagnostics Inc.
ConcertAI
Median Technologies
PathAI
Azra AI
IBM
Siemens Healthcare GmbH